CARSO Group has acquired a majority stake in AQCF Group
CARSO Group, a leading provider of testing services, has acquired a majority stake in AQCF Group, a key player in the field of food safety.
Founded in 1992 and hearquartered in France, CARSO Group is one of the leading providers of analytical services in the French market, with activities in neighboring countries. The wide range of analysis offered includes water and environment testing, occupational hygiene and building health, food, genetics and pharma analysis. In 2021, ARCHIMED became CARSO Group’s majority shareholder, in partnership with CAPZA, Siparex, the management team and the founders. Since becoming the majority shareholder, ARCHIMED has supported the company’s organic and external growth across Europe, through mergers and partnerships in the most attractive market segments. The common objective is to strengthen CARSO’s position as an independent, entrepreneurial and international platform in the world of analytical services.
Founded in 2007 and COFRAC-accredited, AQCF Group provides all players in the agri-food sector with its skills and know-how in quality, safety and environmental management, offering a wide range of analysis for food and water quality control, consultancy services in food hygiene and safety, consultancy services in laboratory layout and restructuring, and customized training.
Oaklins’ team in France advised CARSO Group and its shareholders on the acquisition of AQCF Group.
Contáctese con el equipo de la transacción
Transacciones relacionadas
Den Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Conozca másXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Conozca másMicrofinanciera Fundeser has been sold to Grupo Financiero Atlántida
Incofin has successfully exited its investment in Microfinanciera Fundeser in Nicaragua through two of its funds: Rural Impulse Fund II (RIF II) and agRIF. It has sold 100% of its stake in Microfinanciera Fundeser to Grupo Financiero Atlántida through its subsidiary, Inversiones Tres Lagos.
Conozca más